These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9321983)

  • 1. Mechanism of anti-proliferative action of eicosapentaenoic acid (EPA) in vascular cell growth: its effect on signal transduction system.
    Terano T; Hirai A; Shiina T; Tamura Y; Saitoh Y
    Adv Exp Med Biol; 1997; 407():399-404. PubMed ID: 9321983
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid].
    Tamura Y; Hirai A; Terano T; Saitoh H
    Nihon Rinsho; 1992 Feb; 50(2):403-7. PubMed ID: 1613998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats.
    Adan Y; Shibata K; Sato M; Ikeda I; Imaizumi K
    Biosci Biotechnol Biochem; 1999 Jan; 63(1):111-9. PubMed ID: 10052130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiatherogenic action of eicosapentaenoic acid (EPA) in multiple oral doses.
    Yamaguchi K; Mizota M; Hashizume H; Kumagai A
    Prostaglandins Leukot Med; 1987 Jun; 28(1):35-43. PubMed ID: 3039536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy using cilostazol, a specific PDE3 inhibitor.
    Ikeda Y
    Thromb Haemost; 1999 Aug; 82(2):435-8. PubMed ID: 10605734
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dietary fish oil on platelet aggregability: comparison between two oils with different eicosapentaenoic to arachidonic acid ratio.
    Bandyopadhyay I; Saha S; Dutta J
    Biochem Int; 1991 Dec; 25(5):919-28. PubMed ID: 1804110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspirin and hemostasis].
    Samama MM; Elalamy I
    Rev Med Interne; 2000 Mar; 21 Suppl 1():27s-34s. PubMed ID: 10763202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals.
    Terano T; Shiina T; Tamura Y
    Lipids; 1996 Mar; 31 Suppl():S301-4. PubMed ID: 8729139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-atherosclerotic effect of fibrates and eicosapentaenoic acid].
    Sakamoto Y; Node K
    Nihon Rinsho; 2011 Jan; 69(1):87-91. PubMed ID: 21226266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glybenclamide: an antidiabetic with in vivo antithrombotic activity.
    Ting HJ; Khasawneh FT
    Eur J Pharmacol; 2010 Dec; 649(1-3):249-54. PubMed ID: 20858477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid suppresses PDGF-induced DNA synthesis in rat mesangial cells: involvement of thromboxane A2.
    Schmitz PG; Zhang K; Dalal R
    Kidney Int; 2000 Mar; 57(3):1041-51. PubMed ID: 10720956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current issues in thrombosis prevention with antiplatelet drugs.
    de Gaetano G; Cerletti C; Dejana E; Vermylen J
    Drugs; 1986 Jun; 31(6):517-49. PubMed ID: 3525085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid.
    Tamura Y; Hirai A; Terano T; Yoshida S; Takenaga M; Kitagawa H
    Jpn Circ J; 1987 Apr; 51(4):471-7. PubMed ID: 3039190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
    Berrettini M; De Cunto M; Romanelli A; Volpato I; Orzalesi G; Nenci GG
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):309-15. PubMed ID: 9704127
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin: redundant in users of nonaspirin, nonsteroidal antiinflammatory agents?
    Ray WA; Murray KT
    Am Heart J; 2002 Mar; 143(3):381-2. PubMed ID: 11868040
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of arachidonic acid metabolites to atherosclerosis.
    Dembińska-Kieć A; Gryglewski RJ
    Wien Klin Wochenschr; 1986 Apr; 98(7):198-206. PubMed ID: 3010578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats.
    Nieuwenhuys CM; Hornstra G
    Biochim Biophys Acta; 1998 Feb; 1390(3):313-22. PubMed ID: 9487152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prostanoids and their precursors on the aggregation of rainbow trout thrombocytes.
    Hill DJ; Hallett MB; Rowley AF
    Am J Physiol; 1999 Mar; 276(3):R659-64. PubMed ID: 10070125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans.
    von Schacky C; Fischer S; Weber PC
    J Clin Invest; 1985 Oct; 76(4):1626-31. PubMed ID: 2997286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.